Qube Research & Technologies (QRT)’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4	Closed	-$25	–	5008
2023 Q4	$25	Hold	4	–	–	﹤0.01%	4122
2023 Q3	$17	Buy	+4	New	+$16	﹤0.01%	3898

Qube Research & Technologies (QRT)'s FRLN Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2024, closing a stake of 4 shares — an estimated $25 sold.

Qube Research & Technologies (QRT) first reported a position in FRLN in Q3 2023 and held it in 2 quarters. The position peaked at $25 in Q4 2023. 0 funds tracked by Wall St. Rank hold FRLN as of Q1 2024.

Qube Research & Technologies (QRT) reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 4 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2024, an estimated $25.
Qube Research & Technologies (QRT) first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2023 and held it in 2 quarters.
Qube Research & Technologies (QRT)'s Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $25 in Q4 2023.
0 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.